Citation Impact
Citing Papers
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014
Sex Differences in Major Bleeding With Glycoprotein IIb/IIIa Inhibitors
2006
Parenteral Anticoagulants
2012 Standout
Hexachlorobenzene (HCB): A review
1979
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Universal Definition of Myocardial Infarction
2007 Standout
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
2001 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Captopril
1988
Oral Anticoagulant Therapy
2012 Standout
Gender-Specific Outcomes After Sirolimus-Eluting Stent Implantation
2007
Therapeutic advances in myocardial microvascular resistance: Unravelling the enigma
2010
Effectiveness of amiodarone on ventricular arrhythmias during and after acute myocardial infarction
1987
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
A Prospective Natural-History Study of Coronary Atherosclerosis
2011 Standout
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
1991 Standout
A structure-based computational workflow to predict liability and binding modes of small molecules to hERG
2020 StandoutNobel
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Isolated Elevation in Troponin T After Percutaneous Coronary Intervention Is Associated With Higher Long-Term Mortality
2006
Mortality and Morbidity in Patients Receiving Encainide, Flecainide, or Placebo
1991 Standout
Protective effects of captopril and enalapril on myocardial ischemia and reperfusion damage of rat
1987
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial
2007
Polychlorinated Biphenyls (PCBs), Dibenzo-p-Dioxins (PCDDs), Dibenzofurans (PCDFs), and Related Compounds: Environmental and Mechanistic Considerations Which Support the Development of Toxic Equivalency Factors (TEFs)
1990 Standout
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
New Anticoagulant Agents: Direct Thrombin Inhibitors
2008
Bivalirudin
2002
Pharmacological and clinical profile of bivalirudin in the treatment of patients with acute coronary syndrome
2009
Angiographic progression of coronary artery disease and the development of myocardial infarction
1988
Arctic contaminants: sources, occurrence and pathways
1992 Standout
Peri-procedural myocardial injury: 2005 update
2005
Third Universal Definition of Myocardial Infarction
2012 Standout
Regional Anesthesia in the Patient Receiving Antithrombotic or Thrombolytic Therapy
2009 Standout
Three-Year Results of Safety and Efficacy of the Everolimus-Eluting Coronary Stent in Women (from the SPIRIT III Randomized Clinical Trial)
2011
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
1992 Standout
Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope
1988
The Glut athione S-Transferase Supergene Family: Regulation of GST and the Contribution of the lsoenzymes to Cancer Chemoprotection and Drug Resistance Part I
1995 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Novel Approaches for Preventing or Limiting Events (Naples) II Trial
2009
Nonpeptide angiotensin II receptor antagonists
1991 Standout
Ranolazine inhibition of hERG potassium channels: Drug–pore interactions and reduced potency against inactivation mutants
2014
Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology
2006
Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
1988 Standout
Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction
2004
Potential halogenated industrial carcinogenic and mutagenic chemicals
1979
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
A Randomized Trial of Immediate versus Delayed Elective Angioplasty after Intravenous Tissue Plasminogen Activator in Acute Myocardial Infarction
1987
Role of heparin after intravenous thrombolytic therapy for acute myocardial infarction
1987
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Acute Myocardial Infarction in Women
2016
Adverse Reactions with Angiotensin Converting Enzyme (ACE) Inhibitors
1986
Flecainide: Its proarrhythmic effect and expected changes on the surface electrocardiogram
1984
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Different patterns of hepatic microsomal enzyme activity produced by administration of pure hexachlorobiphenyl isomers and hexachlorobenzene
1976
Fourth Universal Definition of Myocardial Infarction (2018)
2018 Standout
Clinical End Points in Coronary Stent Trials
2007 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Coronary Plaque Disruption
1995 Standout
Impact of Clinical Syndrome Acuity on the Differential Response to 2 Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Coronary Stenting
2002
Bradykinin B1 and B2 receptors both have protective roles in renal ischemia/reperfusion injury
2007 StandoutNobel
Fourth universal definition of myocardial infarction (2018)
2018 Standout
2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 Standout
Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty).
1988 Standout
Biodegradation of alpha-hexachlorocyclohexane
1975
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Chlorinated Phenols: Occurrence, Toxicity, Metabolism, And Environmental Impact
1980
Degradation of chlorophenols by means of advanced oxidation processes: a general review
2003 Standout
Polymeric materials based on silk proteins
2008 Standout
Molecular Bases of the Acute Coronary Syndromes
1995 Standout
Works of Henry Lui being referenced
Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial
2001
Comparative Pharmacodynamic Evaluation of Eptifibatide and Abciximab in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: The TAM2 Study
2004
Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: An ESPRIT substudy
2002
Gender-based outcomes after paclitaxel-eluting stent implantation in patients with coronary artery disease
2005
Effect of eptifibatide on coronary flow reserve following coronary stent implantation (An ESPRIT substudy)
2001
Importance of follow-up medical and surgical approaches to prevent reinfarction, reocclusion, and recurrent angina following intracoronary thrombolysis with streptokinase in acute myocardial infarction
1982
Flecainide-induced QT prolongation and ventricular tachycardia
1982
Comparison of intravenous mexiletine and lidocaine for the treatment of ventricular arrhythmias
1986
Dosage, pharmacological effects and clinical outcomes for bivalirudin in percutaneous coronary intervention.
2000
Comparative analysis of the hemodynamic actions of captopril and sodium nitroprusside in severe chronic congestive heart failure
1982
Complementary combined captopril and terbutaline therapy in severe chronic congestive heart failure
1982
Hepatic metabolism of hexachlorobenzene in rats
1975